JP2024529400A5 - - Google Patents
Info
- Publication number
- JP2024529400A5 JP2024529400A5 JP2024503721A JP2024503721A JP2024529400A5 JP 2024529400 A5 JP2024529400 A5 JP 2024529400A5 JP 2024503721 A JP2024503721 A JP 2024503721A JP 2024503721 A JP2024503721 A JP 2024503721A JP 2024529400 A5 JP2024529400 A5 JP 2024529400A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- hbv
- rna molecule
- cells
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163224581P | 2021-07-22 | 2021-07-22 | |
| US63/224,581 | 2021-07-22 | ||
| PCT/US2022/073981 WO2023004375A2 (en) | 2021-07-22 | 2022-07-21 | Hepatitis b virus (hbv) knockouts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529400A JP2024529400A (ja) | 2024-08-06 |
| JP2024529400A5 true JP2024529400A5 (enExample) | 2025-07-30 |
Family
ID=84978767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503721A Pending JP2024529400A (ja) | 2021-07-22 | 2022-07-21 | Ｂ型肝炎ウイルス（ｈｂｖ）ノックアウト |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240350665A1 (enExample) |
| EP (1) | EP4373518A2 (enExample) |
| JP (1) | JP2024529400A (enExample) |
| KR (1) | KR20240087635A (enExample) |
| CN (1) | CN118355348A (enExample) |
| AU (1) | AU2022315298A1 (enExample) |
| CA (1) | CA3226445A1 (enExample) |
| IL (1) | IL310290A (enExample) |
| WO (1) | WO2023004375A2 (enExample) |
| ZA (1) | ZA202401319B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026523341A (ja) | 2023-05-15 | 2026-07-14 | エヌクロマ・バイオ，インコーポレーテッド | Ｈｂｖ遺伝子発現のエピジェネティック調節のための組成物および方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105899658B (zh) * | 2013-12-12 | 2020-02-18 | 布罗德研究所有限公司 | 针对hbv和病毒性疾病以及障碍的crispr-cas系统和组合物的递送、用途和治疗应用 |
| WO2016197132A1 (en) * | 2015-06-04 | 2016-12-08 | Protiva Biotherapeutics Inc. | Treating hepatitis b virus infection using crispr |
| KR101842131B1 (ko) * | 2016-09-05 | 2018-03-27 | 연세대학교 산학협력단 | Hbv를 표적으로 하는 유전자 가위 및 이를 포함하는 hbv 감염 치료용 조성물 |
| JP7679309B2 (ja) * | 2019-05-10 | 2025-05-19 | ビーム セラピューティクス インク． | Ｂ型肝炎を治療するための組成物及び方法 |
-
2022
- 2022-07-21 AU AU2022315298A patent/AU2022315298A1/en not_active Abandoned
- 2022-07-21 IL IL310290A patent/IL310290A/en unknown
- 2022-07-21 CN CN202280063407.1A patent/CN118355348A/zh active Pending
- 2022-07-21 WO PCT/US2022/073981 patent/WO2023004375A2/en not_active Ceased
- 2022-07-21 JP JP2024503721A patent/JP2024529400A/ja active Pending
- 2022-07-21 US US18/291,051 patent/US20240350665A1/en active Pending
- 2022-07-21 KR KR1020247005820A patent/KR20240087635A/ko active Pending
- 2022-07-21 EP EP22846827.8A patent/EP4373518A2/en active Pending
- 2022-07-21 CA CA3226445A patent/CA3226445A1/en active Pending
-
2024
- 2024-02-12 ZA ZA2024/01319A patent/ZA202401319B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024038327A5 (enExample) | ||
| US20230287401A1 (en) | Rna guided compositions for preventing and treating hepatitis b virus infections | |
| JP6799058B2 (ja) | アレル選択的な遺伝子編集およびその使用 | |
| KR102501980B1 (ko) | 화학적으로 변형된 단일 가닥 rna-편집 올리고뉴클레오타이드 | |
| EP3359677B1 (en) | Compositions and methods for treating fragile x syndrome and related syndromes | |
| AU2016335572B2 (en) | Compositions and methods for treating Huntington's disease and related disorders | |
| JP2024038326A5 (enExample) | ||
| JP2020512845A5 (enExample) | ||
| WO2017181107A2 (en) | Modified cpf1 mrna, modified guide rna, and uses thereof | |
| CN112533627A (zh) | 序列特异性体内细胞靶向 | |
| JP2018529732A5 (enExample) | ||
| JP2020513784A5 (enExample) | ||
| JP2002272489A5 (enExample) | ||
| TW202120689A (zh) | 用於降低PAPD5及PAPD7 mRNA以治療B型肝炎感染之核酸分子 | |
| JP2018088888A (ja) | Ｓｃｎ１ａ遺伝子の発現増強法 | |
| TW202006138A (zh) | Fubp1抑制劑用於治療b型肝炎病毒感染之用途 | |
| EP3420093B1 (en) | Micelle based system nuclease encapsulation for in-vivo gene editing | |
| JP2024534639A5 (enExample) | ||
| CN121816416A (zh) | 用于表观遗传调控hbv基因表达的组合物和方法 | |
| TW202417017A (zh) | 具有化學修飾的導引rna | |
| EP3641785A1 (en) | Anti-hbv combination therapies involving specific endonucleases | |
| CN114391040A (zh) | 用于调节载脂蛋白b(apob)基因表达的组合物和方法 | |
| CN113453727A (zh) | 异源核酸的最适ps修饰模式 | |
| CN102178959A (zh) | 抑制肺转移肿瘤生长的siRNA及其寡聚核酸组合与应用 | |
| JP2023538537A (ja) | 核酸の標的化除去のための方法 |